Cargando…

Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial

PURPOSE: This study aimed to investigate whether a reduction in daily sedentary behavior (SB) improves insulin sensitivity in adults with metabolic syndrome in 6 months, without adding intentional exercise training. METHODS: Sixty-four sedentary inactive middle-age adults with overweight and metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: SJÖROS, TANJA, LAINE, SAARA, GARTHWAITE, TARU, VÄHÄ-YPYÄ, HENRI, LÖYTTYNIEMI, ELIISA, KOIVUMÄKI, MIKKO, HOUTTU, NOORA, LAITINEN, Kirsi, KALLIOKOSKI, Kari K., SIEVÄNEN, HARRI, VASANKARI, TOMMI, KNUUTI, JUHANI, HEINONEN, ILKKA H.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924963/
https://www.ncbi.nlm.nih.gov/pubmed/36251378
http://dx.doi.org/10.1249/MSS.0000000000003054
_version_ 1784887963183742976
author SJÖROS, TANJA
LAINE, SAARA
GARTHWAITE, TARU
VÄHÄ-YPYÄ, HENRI
LÖYTTYNIEMI, ELIISA
KOIVUMÄKI, MIKKO
HOUTTU, NOORA
LAITINEN, Kirsi
KALLIOKOSKI, Kari K.
SIEVÄNEN, HARRI
VASANKARI, TOMMI
KNUUTI, JUHANI
HEINONEN, ILKKA H.A.
author_facet SJÖROS, TANJA
LAINE, SAARA
GARTHWAITE, TARU
VÄHÄ-YPYÄ, HENRI
LÖYTTYNIEMI, ELIISA
KOIVUMÄKI, MIKKO
HOUTTU, NOORA
LAITINEN, Kirsi
KALLIOKOSKI, Kari K.
SIEVÄNEN, HARRI
VASANKARI, TOMMI
KNUUTI, JUHANI
HEINONEN, ILKKA H.A.
author_sort SJÖROS, TANJA
collection PubMed
description PURPOSE: This study aimed to investigate whether a reduction in daily sedentary behavior (SB) improves insulin sensitivity in adults with metabolic syndrome in 6 months, without adding intentional exercise training. METHODS: Sixty-four sedentary inactive middle-age adults with overweight and metabolic syndrome (mean (SD) age, 58 (7) yr; mean (SD) body mass index, 31.6 (4.3) kg·m(−2); 27 men) were randomized into intervention and control groups. The 6-month individualized behavioral intervention supported by an interactive accelerometer and a mobile application aimed at reducing daily SB by 1 h compared with baseline. Insulin sensitivity by hyperinsulinemic euglycemic clamp, body composition by air displacement plethysmography, and fasting blood samples were analyzed before and after the intervention. SB and physical activity were measured with hip-worn accelerometers throughout the intervention. RESULTS: SB decreased by 40 (95% confidence interval, 17–65) min·d(−1), and moderate-to-vigorous physical activity increased by 20 (95% confidence interval, 11–28) min·d(−1) on average in the intervention group with no significant changes in these outcomes in the control group. After 6 months, fasting plasma insulin decreased (~1 mU·L(−1)) in the intervention group compared with the control group (time–group, P = 0.0081), but insulin sensitivity did not change in either group. The changes in body mass or adiposity did not differ between groups. Among all participants, the changes in SB and body mass correlated inversely with the change in insulin sensitivity (r = −0.31, −0.44; P = 0.025, 0.0005, respectively). CONCLUSIONS: An intervention aimed at reducing daily SB resulted in slightly decreased fasting insulin, but had no effects on insulin sensitivity or body adiposity. However, as the change in insulin sensitivity associated with the changes in SB and body mass, multifaceted interventions targeting to weight loss are likely to be beneficial in improving whole-body insulin sensitivity.
format Online
Article
Text
id pubmed-9924963
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-99249632023-02-14 Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial SJÖROS, TANJA LAINE, SAARA GARTHWAITE, TARU VÄHÄ-YPYÄ, HENRI LÖYTTYNIEMI, ELIISA KOIVUMÄKI, MIKKO HOUTTU, NOORA LAITINEN, Kirsi KALLIOKOSKI, Kari K. SIEVÄNEN, HARRI VASANKARI, TOMMI KNUUTI, JUHANI HEINONEN, ILKKA H.A. Med Sci Sports Exerc Clinical Sciences PURPOSE: This study aimed to investigate whether a reduction in daily sedentary behavior (SB) improves insulin sensitivity in adults with metabolic syndrome in 6 months, without adding intentional exercise training. METHODS: Sixty-four sedentary inactive middle-age adults with overweight and metabolic syndrome (mean (SD) age, 58 (7) yr; mean (SD) body mass index, 31.6 (4.3) kg·m(−2); 27 men) were randomized into intervention and control groups. The 6-month individualized behavioral intervention supported by an interactive accelerometer and a mobile application aimed at reducing daily SB by 1 h compared with baseline. Insulin sensitivity by hyperinsulinemic euglycemic clamp, body composition by air displacement plethysmography, and fasting blood samples were analyzed before and after the intervention. SB and physical activity were measured with hip-worn accelerometers throughout the intervention. RESULTS: SB decreased by 40 (95% confidence interval, 17–65) min·d(−1), and moderate-to-vigorous physical activity increased by 20 (95% confidence interval, 11–28) min·d(−1) on average in the intervention group with no significant changes in these outcomes in the control group. After 6 months, fasting plasma insulin decreased (~1 mU·L(−1)) in the intervention group compared with the control group (time–group, P = 0.0081), but insulin sensitivity did not change in either group. The changes in body mass or adiposity did not differ between groups. Among all participants, the changes in SB and body mass correlated inversely with the change in insulin sensitivity (r = −0.31, −0.44; P = 0.025, 0.0005, respectively). CONCLUSIONS: An intervention aimed at reducing daily SB resulted in slightly decreased fasting insulin, but had no effects on insulin sensitivity or body adiposity. However, as the change in insulin sensitivity associated with the changes in SB and body mass, multifaceted interventions targeting to weight loss are likely to be beneficial in improving whole-body insulin sensitivity. Lippincott Williams & Wilkins 2023-03 2022-10-13 /pmc/articles/PMC9924963/ /pubmed/36251378 http://dx.doi.org/10.1249/MSS.0000000000003054 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Sports Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Sciences
SJÖROS, TANJA
LAINE, SAARA
GARTHWAITE, TARU
VÄHÄ-YPYÄ, HENRI
LÖYTTYNIEMI, ELIISA
KOIVUMÄKI, MIKKO
HOUTTU, NOORA
LAITINEN, Kirsi
KALLIOKOSKI, Kari K.
SIEVÄNEN, HARRI
VASANKARI, TOMMI
KNUUTI, JUHANI
HEINONEN, ILKKA H.A.
Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial
title Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial
title_full Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial
title_fullStr Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial
title_full_unstemmed Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial
title_short Reducing Sedentary Time and Whole-Body Insulin Sensitivity in Metabolic Syndrome: A 6-Month Randomized Controlled Trial
title_sort reducing sedentary time and whole-body insulin sensitivity in metabolic syndrome: a 6-month randomized controlled trial
topic Clinical Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924963/
https://www.ncbi.nlm.nih.gov/pubmed/36251378
http://dx.doi.org/10.1249/MSS.0000000000003054
work_keys_str_mv AT sjorostanja reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT lainesaara reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT garthwaitetaru reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT vahaypyahenri reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT loyttyniemieliisa reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT koivumakimikko reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT houttunoora reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT laitinenkirsi reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT kalliokoskikarik reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT sievanenharri reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT vasankaritommi reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT knuutijuhani reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial
AT heinonenilkkaha reducingsedentarytimeandwholebodyinsulinsensitivityinmetabolicsyndromea6monthrandomizedcontrolledtrial